ABMGG LGG study materials
ABMGG LGG study resources

Prenatal Microarray With a Variant of Uncertain Significance and a Noisy Phenotype

ABMGG LGG · Put your knowledge to work in context.

All case studies

Prenatal Microarray With a Variant of Uncertain Significance and a Noisy Phenotype

A 34-year-old G2P1 woman at 20 weeks undergoes amniocentesis for a fetal cardiac defect (ventricular septal defect plus overriding aorta on ultrasound) and a two-vessel cord. Chromosomal microarray on amniocytes reports a 410 kb interstitial deletion at 15q13.3 involving CHRNA7, classified by the laboratory as a variant of uncertain significance. Parental testing shows the deletion is maternally inherited; the mother is 34, has a history of one febrile seizure in childhood, completed college, and has no formal psychiatric diagnosis, though she reports lifelong mild social anxiety. The couple asks whether the deletion 'explains the heart defect' and whether they should consider termination. The genetic counselor has 45 minutes and the maternal-fetal medicine team wants a recommendation before the next ultrasound in 3 days.

1. How should the counselor frame the relationship between the 15q13.3 deletion and the fetal cardiac defect?

Read the worked answer

The counselor should separate two questions: (1) does this CNV cause the cardiac defect, and (2) what is the neurodevelopmental prognosis.

For (1): 15q13.3 microdeletion (CHRNA7-containing) is associated primarily with neurodevelopmental and psychiatric phenotypes (developmental delay, ASD, epilepsy, schizophrenia risk) and is incompletely penetrant. It is not a recognized cause of conotruncal or septal cardiac malformations. The cardiac defect is therefore best managed as an independent structural anomaly requiring its own workup (fetal echocardiography, consideration of karyotype if not already done, and possibly a targeted gene panel for cardiac disease if the microarray is otherwise normal). Attributing the heart defect to the CNV risks anchoring the workup and giving the family false closure.

Key teaching point: phenotypic plausibility matters for VUS interpretation. A CNV whose known spectrum does not include the observed anomaly should not be used to 'explain' it.

2. The mother carries the same deletion and is reportedly unaffected. How does this affect interpretation and counseling?

Read the worked answer

Maternal inheritance from a reportedly unaffected parent is a data point but not exoneration. The 15q13.3 deletion shows reduced penetrance (roughly 10-50% depending on phenotype and ascertainment) and variable expressivity; many adult carriers are ascertained only after a child's diagnosis. The mother's history of a febrile seizure and social anxiety is not clearly normal - the counselor should take a careful, structured history (seizures, learning, psychiatric, developmental) rather than accepting 'unaffected' at face value.

Counseling should convey: (a) the fetus inherits a CNV that confers increased risk of developmental delay, epilepsy, and psychiatric illness, but many carriers function well; (b) risk is probabilistic, not deterministic; (c) the maternal phenotype provides a within-family reference point but cannot be used to predict the child's outcome; (d) the laboratory's VUS classification reflects uncertainty about pathogenicity, not benignity.

Practical step: document the maternal phenotype carefully and consider whether reclassification is warranted; a genetics evaluation of the mother may inform the family's understanding.

3. What is the appropriate response to the family's question about termination, given the 3-day timeline?

Read the worked answer

The counselor should not steer toward or away from termination, but must ensure the decision is informed and time-appropriate. Components:

  • Clarify what is known vs. unknown: the cardiac defect is a structural finding with its own prognosis (needs pediatric cardiology input); the CNV adds probabilistic neurodevelopmental risk that cannot be quantified precisely.
  • Avoid implying the CNV 'causes' the heart defect, which would distort the decision.
  • Offer referral to pediatric cardiology and, if desired, a second genetics opinion before the deadline; 3 days is short but the family should not be rushed into a decision based on incomplete information.
  • Explore the family's values and prior experience with disability without imposing a framework.
  • Document the discussion and ensure the family knows they can continue the pregnancy and pursue postnatal evaluation.

The judgment being tested: resisting the pressure to give a tidy causal story under time pressure, and keeping the decision non-directive while correcting the misattribution.